SOURCE-LINKED STUDY SUMMARY
Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging.
Abstract summarizedQuality not appraised
- What was studied
- Laboratory experiments investigated elamipretide and reproductive aging.
- Who / model studied
- Aged mice and human and porcine oocytes; no treated-patient fertility trial.
- Studied dose & schedule
- Mouse administration and laboratory oocyte exposure; exact doses and durations were absent from the abstract.
- What the study found
- Mouse litter size and oocyte quality improved. Human-oocyte maturation, fertilization and cleavage improved in culture. Mitochondrial and vitamin B6–VEGF signaling changes accompanied these findings.
- Limitations & context
- These experiments do not demonstrate improved pregnancy or live-birth outcomes in treated women. Sample accounting, effect sizes and reproductive safety require full-text assessment. Abstract-based summary.
Read summary source ↗ · Prepared 10/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1111/acel.70749